Traws Pharma Inc. (TRAW)
NASDAQ: TRAW
· Real-Time Price · USD
1.51
-0.11 (-6.79%)
At close: Aug 15, 2025, 3:59 PM
1.46
-3.31%
After-hours: Aug 15, 2025, 07:51 PM EDT
Traws Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 20.54B | -140.05M | -166.52M | -140.78M | -137.05M | -18.16M | -18.95M | -20.18M | -20.84M | -20.62M | -18.96M | -17.31M | -15.36M | -15.57M | -16.16M | -18.83M | -21.62M | -24.78M |
Depreciation & Amortization | 2M | 9K | 12K | 14K | 17K | 17K | 16K | 16K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 14K | 15K | 13K |
Stock-Based Compensation | 266.68M | 1.22M | 1.39M | 1.39M | 1.41M | 1.3M | 1.3M | 969K | 609K | 336K | n/a | n/a | n/a | n/a | 65K | 159K | 249K | 341K |
Other Working Capital | -582K | -4.83M | -5.47M | -5.48M | -6.12M | -2.64M | -2.06M | -904K | 701K | 1.08M | 382K | -195K | -863K | -574K | -1.53M | -451K | -348K | 573K |
Other Non-Cash Items | -32.23B | 115.39M | 141.9M | 118.33M | 117.63M | 269K | -437K | -1.07M | -807K | -544K | 98K | 1.42M | 1.77M | 733K | 1.43M | 17K | 53K | 781K |
Deferred Income Tax | n/a | n/a | n/a | -869K | -163K | -269K | 437K | 1.31M | 600K | 706K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.24M | -7.37M | -6.57M | -8.26M | -5.01M | -972K | -301K | 1.48M | 2.77M | 2.85M | 1.48M | -484K | -2.15M | -1.43M | -3.59M | -2.11M | -1.19M | 385K |
Operating Cash Flow | -11.43B | -30.8M | -29.79M | -30.18M | -23.18M | -17.81M | -17.93M | -17.39M | -16.82M | -16.54M | -16.29M | -16.68M | -17.04M | -17.14M | -19.49M | -20.69M | -22.19M | -23.26M |
Capital Expenditures | n/a | n/a | n/a | n/a | -14K | -14K | -14K | -14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15K |
Cash Acquisitions | -3,648B | -3,648B | -3,648B | -3.65M | -3.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 3,648B | 3,648B | 3,648B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -3.65M | -3.65M | -3.65M | -3.66M | -14K | -14K | -14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.11B | -109K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7K | 504K | 783K | 3.5M | 5.08M |
Financial Cash Flow | 3.13B | 33.99M | 33.98M | 14M | 14M | n/a | n/a | n/a | n/a | n/a | n/a | -35K | 19.91M | 19.92M | 55.56M | 55.87M | 38.65M | 40.22M |
Net Cash Flow | 13.06B | -453K | 517K | -19.83M | -12.84M | -17.83M | -17.94M | -17.37M | -16.8M | -16.55M | -16.31M | -16.77M | 2.83M | 2.77M | 36.05M | 35.18M | 16.48M | 16.97M |
Free Cash Flow | -11.43B | -30.8M | -29.79M | -30.18M | -23.19M | -17.83M | -17.95M | -17.4M | -16.82M | -16.54M | -16.29M | -16.68M | -17.04M | -17.14M | -19.49M | -20.69M | -22.19M | -23.27M |